TrialJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2013

Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial.

Michael Anstead et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.